precise-genome-editing.com - Home - Vector Biopharma

Example domain paragraphs

Home About People Technology Publications Partnering Investors Careers News Contact window.addEventListener("load", function() { if(screen.width > 999) { document.querySelector(".menu-toggle").remove(); const links = document.querySelector("#primary-menu").querySelectorAll('a'); const sections = document.querySelectorAll('.scroll-section'); const homeLogo = document.querySelector(".home-logo"); const masthead = document.querySelector("#masthead"); function changeLinkState() { let index = sections.length; wh

We develop next-generation therapeutics using our proprietary platform that delivers the right gene to the right place at the right time with unparalleled precision and versatility.

Lorenz Mayr, Ph.D. is the Chief Executive Officer and co-founder of Vector BioPharma. A biochemist, biophysicist and molecular biologist by training, he started his industry career at Bayer, subsequently assuming global roles of increasing responsibility at Novartis (Executive Director), AstraZeneca (VP and Global Head, Reagents and Assay Development), and GE Healthcare Life Sciences (Chief Technology Officer, Head of R&D). Prior to joining Vector, Lorenz was Entrepreneur-in-Residence at Syncona. He holds B